In thyrotoxic periodic paralysis, hypokalemia and hypophosphatemia are highly prevalent, and potassium administration carries a significant risk of rebound hyperkalemia.
May warrant caution with potassium repletion in thyrotoxic periodic paralysis; leaves open prospective evaluation of risks and alternatives.
Hypokalemia, hypophosphatemia, and mild hypomagnesemia are characteristic features of TPP. Hypokalemia occurred in 100% and hypophosphatemia in 80% of the episodes in our study. Rebound hyperkalemia is a potential hazard of potassium administration and occurred in 42% of 24 episodes.
No takes yet. Share an insight, caveat, or question.
Manoukian et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: